brain and encodes a protein that localizes specifically to predominately expressed in brain regions associated with long-term potentiation (LTP) or LTD, electrophysiothe postsynaptic endocytic zone of excitatory synapses. We present evidence that CPG2 is a critical component logical paradigms of synaptic plasticity. of the postsynaptic endocytic pathway that mediates both constitutive and activity-regulated glutamate re-CPG2 Localizes to the Postsynaptic Site ceptor internalization. We hypothesize that CPG2 is a of Excitatory Synapses key component of a specialization that is devoted to Consistent with its derivation from the Syne-1 separator the internalization of postsynaptic proteins at synapses region, the CPG2 protein contains predicted structural capable of plasticity.
or protein interaction motifs including two spectrin repeats and several coiled coils (Figure 2A ). To gain insight into CPG2 function, we first determined its localization Results within neurons. To this end, we generated a monoclonal antibody against a peptide from CPG2. When used to Analysis of cpg2 Exon/Intron Structure and Transcript Distribution probe a Western blot containing protein extracts from rat cerebral cortex, this antibody recognized a doublet A partial cpg2 cDNA isolated in a screen for activityregulated genes (Nedivi et al., 1993 ) was used as a probe band of the predicted size of CPG2 ( Figure 2B , lane 1). Protein extracts from 293T cells transfected with the to obtain a full-length cpg2 clone from a rat dentate gyrus cDNA library (Nedivi et al., 1996) . The full-length cpg2 cDNA showed the same-sized doublet band (Figure 2B, lane 2), suggesting that the in vivo doublet does cDNA contains a 2.8 kb open reading frame that predicts a protein of 941 amino acids and is flanked by a 266 not correspond to the translation of the cpg2 and cpg2b transcripts but rather results from posttranslational nucleotide 5Ј untranslated region (UTR) and a 2.3 kb 3ЈUTR (Nedivi et al., 1996) . When using the cpg2 cDNA modification of CPG2 or leaky translation initiation of cpg2. sequence for database searches, we identified the 18 exons of the cpg2 coding region as corresponding to
Immunostaining of cultured hippocampal neurons with the anti-CPG2 monoclonal antibody showed a exons 16 to 33 of the syne-1 gene, with the syne-1 exon 34 contained in the cpg2 3ЈUTR ( Figure 1A) . A Northern punctate staining pattern on dendrites ( Figure 2C ). To further confirm the specificity of the anti-CPG2 monoblot of total RNA from rat cerebral cortex probed with a segment of the cpg2 coding sequence showed a single clonal antibody, neurons were infected with a lentivirus expressing a CPG2-GFP fusion protein and then stained 5.9 kb transcript ( Figure 1B) , the approximate size of the longest cpg2 cDNA clone. Inspection of the cpg2 with the anti-CPG2 antibody. The CPG2-GFP signal showed an overlapping distribution with anti-CPG2 anti-3ЈUTR revealed the likely sites of syne-1 early transcription and translation termination that generate the cpg2 body labeling of CPG2 ( Figure 2D ), demonstrating that the CPG2 antibody recognizes endogenous CPG2 protranscript. The cpg2 3ЈUTR contains an unspliced intron between exons 33 and 34 of the syne-1 gene. Exon 34 tein and the CPG2-GFP protein and results in no other detectable signal in neurons. We observed no labeling is followed by a noncanonical polyadenylation hexamer, conserved in rats and humans, which likely serves as when neurons were stained with an antibody against the Syne-1 C terminus previously shown to recognize the site of cpg2 transcription termination ( Figure 1C chemistry data, we suggest that the immunostaining patterns seen with the anti-CPG2 monoclonal antibody To determine whether the original cpg2 cDNA contains the complete 5ЈUTR, we used 5ЈRACE to map the result from staining of the CPG2 protein and not the product of another syne-1 splice variant. cpg2 mRNA start site and isolated two separate bands ( Figure 1D ). Subcloning and sequencing these bands Since the punctate distribution of CPG2 in hippocampal neurons was indicative of a synaptic localization, we identified two 5Ј ends to the cpg2 transcript. One transcript (cpg2) corresponds to the original cpg2 cDNA tested this possibility by infecting neurons with a GFPexpressing lentivirus and double staining for CPG2 and isolated in the screen. A second transcript (cpg2b; accession number AY597251) contains an additional exon synapsin I. We found that CPG2 was localized apposed to most synapsin I-positive presynaptic terminals at the 5Ј end of the cpg2 coding region ( Figure 1E ) encoding 24 N-terminal residues with no known struc-(89% Ϯ 1%; n Ͼ 500 synapses, 5 neurons), often on dendritic spines ( Figure 2E ). These results suggest that tural domains. To determine the tissue distribution of the two cpg2 transcripts, we performed RT-PCR using CPG2 localizes to the postsynaptic component of a subset of synapses that are often located on dendritic primers that amplify the cpg2 transcripts but not other syne-1 splice variants (see Figure 1E ). Both transcripts spines. To determine the type of synapses containing CPG2, GFP-filled neurons were double labeled for CPG2 were amplified only from brain cDNA, showing that cpg2 and cpg2b are brain-specific splice variants of syne-1 and the inhibitory synapse marker GAD65 or the excitatory synapse marker PSD-95. CPG2 rarely colocalized ( Figure 1F ). Using a probe against the shared cpg2 and cpg2b 3ЈUTR that only recognized the cpg2 transcripts, with GAD65-positive synapses (15% Ϯ 2%; n Ͼ 500 synapses, 5 neurons) ( Figure 2F ) but was consistently in situ hybridization of a sagittal section from an adult rat brain showed that they are expressed in the cerebral observed at PSD-95-positive synapses (94% Ϯ 1%; n Ͼ 500 synapses, 5 neurons) ( Figure 2G ). Additionally, cortex, hippocampus, striatum, and cerebellum of adult rats ( Figure 1G) . Thus, the two cpg2 transcripts are CPG2 was not found at PSD-95-positive excitatory synapses on aspiny presumptive inhibitory neurons (data brain-specific splice variants of the syne-1 gene that are (C) Schematic of the syne-1 genomic DNA sequence at the site of cpg2 transcript termination. Numbers identify the syne-1 exons. The final exon in the cpg2 coding region is marked by the red box, and a noncoding exon contained in the 3ЈUTR is marked in yellow. The intron between these exons is not spliced out in cpg2. Conserved rat and human sequences following the final coding exon ending with the translation stop codon (green) indicate the site of cpg2 translation termination. Sequence following the noncoding exon shows the polyadenylation hexamer (red), the site of cpg2 transcription termination. (D) 5ЈRACE products of rat brain RNA using a primer in the first cpg2 coding exon, followed by PCR using nested primers in reactions with (left lane) or without (right lane) reverse transcriptase. (E) Schematic of two cpg2 splice variants identified by sequencing of the 5ЈRACE fragments. The green box indicates an additional exon spliced to the 5Ј end of the cpg2 transcript. Arrows indicate the locations of RT-PCR primers. (F) Tissue RT-PCR from total RNA using primers specific to cpg2, cpg2b, and ␤-actin. (G) In situ hybridization on a sagittal section through an adult rat brain using a probe from the cpg2 3ЈUTR. not shown). Thus, CPG2 is specifically localized to the proteins, as CPG2 was often localized segregated from the PSD and actin filaments in the spine head ( Figure 3A ). postsynaptic side of excitatory synapses on gluta-CPG2's localization was further resolved using immumatergic neurons.
noEM. In preembedding anti-CPG2 immunoEM, approximately 47% of the labeling was associated with distal CPG2 Localizes to an Endocytic Zone dendrites/dendritic spines, 47% was associated with of Excitatory Synapses cytosol/endoplasmic reticulum in the perikaryon or Close examination of the CPG2 distribution reveals that proximal dendrites, and 6% was associated with PSDs. it does not colocalize with PSD-95 within spines, sugNo immunoreactivity was detected in presynaptic termigesting that CPG2 is not part of the PSD and localizes nals. Of 100 synaptic membrane specializations that to a separate spine domain (see Figure 2G ). To characshowed CPG2 labeling, 100 were asymmetrical, excitterize CPG2's localization in relation to the PSD and atory synapses. No symmetrical, inhibitory synapses the spine cytoskeleton, we stained neurons for actin were identified in association with CPG2 immunoreacfilaments, CPG2, and PSD-95. High-magnification imtivity. At excitatory synapses, CPG2 was localized beages of individual spines from these triple-labeled neuneath the PSD predominantly to the more lateral aspects of the PSD, both in vivo in dendritic spine ( Figure 3B ) rons show little overlap in the distribution of the three Figures 3F and 3G) . Thus, the immunoEM confirms the immunofluorescence data the immunoEM data strongly suggest that CPG2 is localized to an endocytic zone within spines that is distinct and demonstrates that in vivo CPG2 is concentrated in the postsynaptic site of excitatory synapses and is from the postsynaptic density. If the region of CPG2 and clathrin colocalization is localized to a distinct synaptic subdomain, lateral to and beneath the PSD.
an endocytic zone, CPG2 should be associated with clathrin-coated pits and/or vesicles. Figure 4C shows The localization of CPG2 within spines is similar to that of a clathrin-GFP fusion protein previously shown an immunoEM micrograph of a synapse from a cultured neuron where CPG2 is localized near a clathrin-coated to colocalize with endogenous clathrin in neurons and to mark an endocytic zone of excitatory synapses (Blanpit separated from the PSD. Figure 4D shows CPG2 staining pattern is consistent with our immunofluoreshairpin RNA (shRNA) driven by the mouse U6 promoter, that could effectively knock down exogenous cpg2-concence finding that CPG2 is colocalized with clathrin in the postsynaptic endocytic zone and suggests that it taining mRNA transcripts in 293T cells (data not shown; see Experimental Procedures for details). This cpg2-may be involved in the endocytosis of glutamate receptors.
shRNA sequence and the U6 promoter were subcloned into the pFUGW lentivirus transfer vector upstream of the human ubiquitin-C promoter that drives expression CPG2 Levels Affect Dendritic Spine Size CPG2's localization to the postsynaptic endocytic zone of GFP ( Figure 5A ). A mutated cpg2-shRNA (Mcpg2-shRNA) lentivirus was generated as a negative control. suggests that it may regulate the internalization of surface membrane via clathrin-mediated endocytosis.
Western blots of protein extracts from high-density cortical neurons infected with the cpg2-shRNA lentivirus Therefore, we hypothesized that altering CPG2 levels may affect the size of dendritic spines. To test this hyshowed a 90% Ϯ 1% reduction (n ϭ 5 cultures) in CPG2 levels relative to Mcpg2-shRNA-infected neurons (Figpothesis, we manipulated CPG2 protein levels using overexpression or RNA interference (RNAi) and examure 5B). In contrast, there were no changes in levels of GluR1, NR1, or ␤-tubulin ( Figure 5B ). Control and ined the effects on spine morphology.
For CPG2 overexpression, we generated a lentivirus knockdown cultures showed comparable levels of GFP expression, demonstrating a similar infection rate. CPG2 expressing a CPG2-GFP fusion protein driven by the human ubiquitin-C promoter (cpg2-gfp) that increases knockdown was also evident at the synaptic level. Neurons infected with the control Mcpg2-shRNA virus CPG2 levels within dendritic spines of infected neurons by 2-to 3-fold, as assessed by immunostaining (data showed a normal CPG2 subcellular distribution pattern ( Figures 5C and 5E ), whereas neurons infected with not shown). To knock down CPG2 levels in neurons, we developed a lentivirus vector for RNAi delivery. We first cpg2-shRNA showed a reduction in CPG2 levels but no apparent change in the levels or distribution of PSD-95 generated a plasmid expressing a cpg2-specific small ( Figure 5D ), synapsin ( Figure 5F ), or actin filaments (data delivered by a lentivirus vector effectively knocks down endogenous CPG2 levels in cultured neurons. not shown). In addition, a lentivirus delivering a shRNA that knocks down the levels of a different candidate
We measured spine head area from control and knockdown neurons of similar size and morphology to plasticity gene, cpg15, had no effect upon CPG2 levels (U. Putz and E.N., unpublished data). Thus, cpg2-shRNA determine if manipulating CPG2 protein levels leads to changes in spine morphology. Figure 5G shows individbiotinylated with a reversible biotin and kept at 4ЊC to block internalization or moved to 37ЊC for 30 min to ual spines from neurons infected with Mcpg2-shRNA, allow for receptor internalization (in the presence of a cpg2-shRNA, and cpg2-gfp. We found that neurons inproteasome inhibitor). Remaining surface biotin was refected with cpg2-shRNA had significantly smaller denmoved with a cell-impermeable cleavage buffer. Biotindritic spine heads (Ϫ18% Ϯ 2.4%; p Ͻ 0.0005; n ϭ 10 ylated proteins were then isolated, probed on a Western cells per group, 100 spines per cell) than Mcpg2-shRNAblot, and compared with calibration controls. In Mcpg2-infected neurons, while cpg2-gfp-infected neurons had shRNA-infected cultures, 6.2% Ϯ 0.8% of surface NMDA larger spine heads (ϩ7% Ϯ 2.1%; p Ͻ 0.05; n ϭ 10 cells receptors and 8.2% Ϯ 0.6% of surface AMPA receptors per group, 100 spines per cell) ( Figure 5H ). In addition, were internalized after 30 min at 37ЊC (Figures 6E and 
CPG2 Knockdown Disrupts Constitutive
The internalization of AMPA and NMDA receptors was Glutamate Receptor Internalization reduced by 66% Ϯ 11% (p Ͻ 0.02) and 73% Ϯ 5% (p Ͻ If CPG2 regulates the removal of synaptic proteins from 0.002), respectively, in cpg2-shRNA-infected neurons the spine surface through vesicle-mediated endocyto-( Figure 6G ). These results demonstrate that the cpg2-sis, then altering its levels may also affect the number shRNA blockade was specific to the internalization of of clathrin-coated pits and vesicles seen within spines. synaptic proteins. The reduction in glutamate receptor Using electron microscopy, we analyzed the number of internalization was not a result of a general reduction synapse-associated clathrin-coated pits and vesicles in in GluR2 or NR1 levels, as total GluR2 and NR1 levels cultured hippocampal neurons infected with either the remained constant in Mcpg2-shRNA-and cpg2-shRNAMcpg2-shRNA or the cpg2-shRNA lentivirus. Figure 6A infected neurons (see Figure 4B ). These data indicate shows examples of spine and shaft synapses from that CPG2 is necessary for normal constitutive gluta protein biotinylation assay. Surface proteins from conTo confirm that the clathrin-coated pits and vesicles trol or CPG2 knockdown neurons were biotinylated, septhat accumulate in response to CPG2 knockdown conarated from total protein using Neutravidin, then run on tain synaptic proteins, we performed preembedding im-SDS-PAGE gels side by side with total protein from the munoEM for NR1 on cpg2-shRNA-treated cultures. In same cells and probed on Western blots with antibodies RNAi-treated cultures, clathrin-coated vesicles near against GluR2 or NR1. We then compared the ratios synapses stained positively for NR1 ( Figure 6C ). In RNAiof surface receptors to total receptors in cpg2-shRNAtreated cultures, 41% Ϯ 11% of coated pits or vesicles treated and control cultures. Knockdown of CPG2 restained for NR1, as opposed to only 0.5% Ϯ 0.5% persulted in a significant increase in the surface to total cent in control cultures (n ϭ 12 neurons; p Ͻ 0.01). No protein ratios for both GluR2 (ϩ25% Ϯ 10%; n ϭ 5; p Ͻ staining was seen on similar vesicles from unstained 0.05) and NR1 (ϩ20% Ϯ 7%; n ϭ 4; p Ͻ 0.05) (Figures  cultures (Figure 6D ). These data suggest that CPG2 reg-7A and 7B), demonstrating that CPG2 knockdown does ulates endocytosis of clathrin-coated pits that traffic result in an increase in surface receptors. Since biotinyglutamate receptors. lation assays measure the amount of both synaptic and There are two potential mechanisms by which CPG2 extrasynaptic receptors, we further examined the levels knockdown can increase the number of postsynaptic of surface AMPA receptors by staining fixed, unpermeclathrin-coated vesicles that traffic glutamate receptors: abilized control and knockdown neurons with an antieither it can increase the rate of their formation, or it body against an extracellular epitope of the GluR1 AMPA can decrease the rate of their removal. To understand receptor subunit. When we quantified the intensity of the mechanism of CPG2's regulation of glutamate reGluR1 punctae, we found that there was a similar inceptor internalization, we performed a biochemical increase in synaptic GluR1 levels in CPG2 knockdown ternalization assay. Surface proteins from cortical culneurons (ϩ18% Ϯ 5%; p Ͻ 0.05; n ϭ 8 to 10 cells per group) (Figures 7C and 7D) . Thus, CPG2 knockdown tures infected with Mcpg2-shRNA or cpg2-shRNA were CPG2 plays a potential role in LTD, we examined the effect of CPG2 knockdown on the activity-induced internalization of AMPA receptors. Control and CPG2 knock-CPG2 Knockdown Disrupts Activity-Induced AMPA Receptor Internalization down neurons were incubated with the anti-GluR1 antibody and then in control media or media plus NMDA, LTD is thought to occur in part by the rapid clathrinmediated internalization of AMPA receptors following followed by fixation and secondary staining for surface GluR1. The intensity of GluR1 punctae was then quantithe activation of a specific set of signaling pathways HIV-1 packaging vector ⌬8.9, and the VSVG envelope glycoprotein with a Diagnostic Instruments Spot2 digital camera mounted on a vector into 293T cells with Lipofectamine 2000 (Invitrogen). Culture Nikon Eclipse E600 using a 60ϫ/1.40 Plan Apo oil immersion objecmedium was collected 48 to 60 hr after transfection, filtered, and tive (Nikon). For quantifications, spine head area from GFP-filled centrifuged at 25,000 RPM for 90 min at 4ЊC. Supernatants were neurons was measured blind to treatment using Scion Image Beta discarded, and the virus pellets were rehydrated overnight in PBS. 4.0.2. Student's t test was used to compare groups. Viral particles were resuspended, aliquoted, and frozen at Ϫ80ЊC. Viral titers were determined by application of serial dilutions to 293T Electron Microscopic Immunocytochemistry cells and quantifications of GFP expression 72 hr later. Typical titers Cultures fixed with 4% paraformaldehyde and 0.1% glutaraldehyde were ‫1ف‬ ϫ 10 6 pfu/l. or vibratome sections of perfusion-fixed rat hippocampi were immuThe overexpression of CPG2 with the cpg2-gfp lentivirus lead to nostained for CPG2 (1.5 g/ml) or NR1 (1:1000; Chemicon) overnight significant toxicity within neurons, likely due to its misexpression. at room temperature. They were then incubated with biotinylated Therefore, analysis of CPG2 overexpression was limited to experihorse anti-mouse secondary antibodies (1:250; Vector) for 2 hr folments where it was possible to use a low titer. For example, measurlowed by incubation in Avidin biotin-peroxidase (1:200; Vector) for ing CPG2's effects upon dendritic spine size could be done on 2 hr at room temperature. Tissue bound peroxidase was then visualisolated healthy neurons overexpressing CPG2 at lower levels. In ized with a diaminobenzidine (DAB; 5 mg/ml, H 2 0 2 0.03%) reaction.
contrast, the effects of CPG2 overexpression could not be tested Coverslips were osmicated, dehydrated, and embedded in durcuin the biochemical assays or in the immunoEM experiments, as pan (FLUKA, ACM). Ultrathin sections (60 nm thick) were prepared these required near 100% infection efficiency, which would result on an Ultracut UCT, Leica ultramicrotome and analyzed in a Tecnai in multiple infections and in significant attrition in cell density. 10 electron microscope. For clathrin-coated pit and vesicle quantifications, neurons randomly selected from unstained Mcpg2-shRNA Biotinylation Internalization Assay (n ϭ 35 cells)-and cpg2-shRNA (n ϭ 28 cells)-infected cultures were High-density cultures were infected at 6 DIV with the Mcpg2-shRNA or cpg2-shRNA lentivirus vectors, resulting in Ͼ95% GFP-expressphotographed at magnification of 55,400. Part of the perykarion and
